ZA883209B - A pharmaceutical combination for the prophylazis and therapy of malaria - Google Patents

A pharmaceutical combination for the prophylazis and therapy of malaria

Info

Publication number
ZA883209B
ZA883209B ZA883209A ZA883209A ZA883209B ZA 883209 B ZA883209 B ZA 883209B ZA 883209 A ZA883209 A ZA 883209A ZA 883209 A ZA883209 A ZA 883209A ZA 883209 B ZA883209 B ZA 883209B
Authority
ZA
South Africa
Prior art keywords
prophylazis
malaria
therapy
pharmaceutical combination
pharmaceutical
Prior art date
Application number
ZA883209A
Other languages
English (en)
Inventor
Kumar Chatterjee Dipak
Venugopalan Bindumadhavan
Lal Bansi
John De Souza Noel
Helmut Rupp Richard
Original Assignee
Hoechst Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Aktiengesellschaft filed Critical Hoechst Aktiengesellschaft
Publication of ZA883209B publication Critical patent/ZA883209B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA883209A 1987-05-08 1988-05-05 A pharmaceutical combination for the prophylazis and therapy of malaria ZA883209B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873715378 DE3715378A1 (de) 1987-05-08 1987-05-08 Arzneimittelkombination zur prophylaxe und therapie von malaria

Publications (1)

Publication Number Publication Date
ZA883209B true ZA883209B (en) 1988-11-08

Family

ID=6327117

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA883209A ZA883209B (en) 1987-05-08 1988-05-05 A pharmaceutical combination for the prophylazis and therapy of malaria

Country Status (11)

Country Link
EP (1) EP0290959A3 (da)
JP (1) JPS6452714A (da)
KR (1) KR880013558A (da)
AU (1) AU614515B2 (da)
DE (1) DE3715378A1 (da)
DK (1) DK249688A (da)
HU (1) HU200688B (da)
IL (1) IL86302A0 (da)
IN (1) IN166154B (da)
PT (1) PT87427B (da)
ZA (1) ZA883209B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916204A (en) * 1987-07-31 1990-04-10 Massachusetts Institute Of Technology Pure polyanhydride from dicarboxylic acid and coupling agent
AU625071B2 (en) * 1988-04-20 1992-07-02 Merrell Dow Pharmaceuticals Inc. N-alkylamino derivatives of aromatic, tricyclic compounds in the treatment of drug-resistant protozoal infections
EP0362810B1 (en) * 1988-10-07 1993-05-05 Hoechst Aktiengesellschaft Antimalarial compositions using quinidine, artemisinine and its derivatives
EP0535719A3 (en) * 1988-12-06 1993-04-14 Dermatologic Research Corporation Treatment of hemorrhoids with artemisinin and derivates
EP0464233A1 (en) * 1990-07-02 1992-01-08 Hoechst Aktiengesellschaft Pharmaceutical combinations against malaria
NZ246606A (en) * 1992-02-07 1995-09-26 Ciba Geigy Ag Antimalarial compostions containing a synergistic combination of benflumetol and quinine or a derivative thereof
GB9622427D0 (en) * 1996-10-28 1997-01-08 Pharma Mar Sa Antimalarial drugs
US6160004A (en) * 1997-12-30 2000-12-12 Hauser, Inc. C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activities
IN191696B (da) * 1999-02-12 2003-12-20 Council Scient Ind Res
AU2000255627A1 (en) * 2000-03-28 2001-10-08 Council Of Scientific And Industrial Research A novel anti-microbial composition and method for producing the same
AU2001295979A1 (en) * 2000-10-20 2002-04-29 Ajinomoto Co., Inc. Medicinal compositions, dose and method for treating malaria
CN1255106C (zh) 2003-09-26 2006-05-10 李国桥 复方青蒿素
WO2006070393A1 (en) * 2004-12-28 2006-07-06 Council Of Scientific And Industrial Research SYNERGISTIC COMBINATION KIT OF α,ß-ARTEETHER, SULFADOXIN AND PYMETHAMINE FOR TREATMENT OF SEVERE/MULTI-DRUG RESISTANT CEREBRAL MALARIA
FR2884715B1 (fr) * 2005-04-20 2007-06-15 Sanofi Aventis Sa Association entre la ferroquine et un derive d'artemisinine pour le traitement du paludisme
WO2007043061A1 (en) * 2005-10-11 2007-04-19 Ipca Laboratories Ltd. Anti-malarial combination and methods of formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU625071B2 (en) * 1988-04-20 1992-07-02 Merrell Dow Pharmaceuticals Inc. N-alkylamino derivatives of aromatic, tricyclic compounds in the treatment of drug-resistant protozoal infections
EP0362810B1 (en) * 1988-10-07 1993-05-05 Hoechst Aktiengesellschaft Antimalarial compositions using quinidine, artemisinine and its derivatives

Also Published As

Publication number Publication date
JPS6452714A (en) 1989-02-28
DE3715378A1 (de) 1988-11-24
KR880013558A (ko) 1988-12-21
EP0290959A2 (de) 1988-11-17
AU614515B2 (en) 1991-09-05
EP0290959A3 (de) 1990-03-07
DK249688A (da) 1988-11-09
IN166154B (da) 1990-03-24
HUT47846A (en) 1989-04-28
HU200688B (en) 1990-08-28
AU1567588A (en) 1988-11-10
PT87427B (pt) 1992-09-30
PT87427A (pt) 1989-05-31
IL86302A0 (en) 1988-11-15
DK249688D0 (da) 1988-05-06

Similar Documents

Publication Publication Date Title
GB2205496B (en) Medicinal or therapeutic pack
CS403391A3 (en) Pharmaceutical
EP0196415A3 (en) Trichostatins a and c as antitumour drugs
ZA883209B (en) A pharmaceutical combination for the prophylazis and therapy of malaria
MW6386A1 (en) Combination preparations for the treatment of malaria
EP0305902A3 (en) Medicament
GB8819490D0 (en) Pharmaceutical devices
EP0412158A4 (en) Oncostatic drug
IE872788L (en) Pharmaceutical combination
GB8719374D0 (en) Pharmaceutical devices
GB8901158D0 (en) Administering drugs
IL82087A0 (en) Medicinal emulsions
GB8705553D0 (en) Medicament
EG18297A (en) New drug preparation
EG18240A (en) New pharmaceutical preparation
IE881376L (en) Anti-malarial pharmaceutical combination
GB8704637D0 (en) Pharmaceutical agents
ZA885842B (en) A device for the administration of implants
GB8707180D0 (en) Medicaments
GB8707178D0 (en) Medicaments
GB8727686D0 (en) Medicaments
GB8727687D0 (en) Medicaments
GB8727688D0 (en) Medicaments
GB8700609D0 (en) Medicaments
GB8728714D0 (en) Medicaments